Gene-specific therapy for inherited arrhythmogenic diseases
- 30 April 2006
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 110 (1) , 1-13
- https://doi.org/10.1016/j.pharmthera.2005.08.003
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Efficacy of Quinidine in High-Risk Patients With Brugada SyndromeCirculation, 2004
- Novel Mechanism for Brugada SyndromeCirculation Research, 2001
- Novel Arrhythmogenic Mechanism Revealed by a Long-QT Syndrome Mutation in the Cardiac Na + ChannelCirculation Research, 2001
- The Brugada Syndrome: Ionic Basis and Arrhythmia MechanismsJournal of Cardiovascular Electrophysiology, 2001
- Molecular Pharmacology of the Sodium Channel Mutation D1790G Linked to the Long-QT SyndromeCirculation, 2000
- Effects of Electrophysiologic‐Guided Therapy with Class IA Antiarrhythmic Drugs on the Long‐Term Outcome of Patients with Idiopathic Ventricular Fibrillation with or without the Brugada SyndromeJournal of Cardiovascular Electrophysiology, 1999
- MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac ArrhythmiaPublished by Elsevier ,1999
- Novel LQT-3 Mutation Affects Na + Channel Activity Through Interactions Between α- and β 1 -SubunitsCirculation Research, 1998
- KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium currentNature, 1996
- INTERMITTENT MUSCULAR WEAKNESS, EXTRASYSTOLES, AND MULTIPLE DEVELOPMENTAL ANOMALIESActa Paediatrica, 1971